HedgeChatter

  • Home /
  • Tag Archives

NVS

Novartis’ meningitis B vaccine wins breakthrough therapy status in U.S.

[Reuters] – Novartis said U.S. health regulators have granted the Swiss drugmaker’s meningitis B vaccine Bexsero breakthrough therapy status. Bexsero is widely seen as crucial to Novartis’ vaccines business, which has struggled to catch market leaders Gl moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click […]

April 7, 2014 Bystocknews , Comments Off on Novartis’ meningitis B vaccine wins breakthrough therapy status in U.S. read more

[$$] Novartis Replaces Top Management in Japan

[at The Wall Street Journal] – Swiss drug giant Novartis installed new top management in Japan and put a freeze on clinical tests as it moves to restore its reputation after a string of questionable practices came to light about its … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who […]

April 4, 2014 Bystocknews , Comments Off on [$$] Novartis Replaces Top Management in Japan read more

[$$] Novartis Replaces Top Management in Japan

[at The Wall Street Journal] – Swiss drug giant Novartis installed new top management in Japan and put a freeze on clinical tests as it moves to restore its reputation after a string of questionable practices came to light about its … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who […]

April 4, 2014 Bystocknews , Comments Off on [$$] Novartis Replaces Top Management in Japan read more

[$$] Microsoft Frames Itself as Underdog

[at The Wall Street Journal] – In his 60 days as Microsoft’s third CEO, Satya Nadella has accelerated the spread of company software to the 85% of computing devices not running Windows, the operating system that made it famous. moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring […]

April 3, 2014 Bystocknews , Comments Off on [$$] Microsoft Frames Itself as Underdog read more

6:51 am Novartis AG: PARADIGM-HF trial of Novartis’ LCZ696 for chronic heart failure closes early based on strength of interim results

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

April 1, 2014 Bystocknews , Comments Off on 6:51 am Novartis AG: PARADIGM-HF trial of Novartis’ LCZ696 for chronic heart failure closes early based on strength of interim results read more

Setback for Novartis

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

March 31, 2014 Bystocknews , Comments Off on Setback for Novartis read more

3 Reasons to Buy Novavax, Inc.

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

March 28, 2014 Bystocknews , Comments Off on 3 Reasons to Buy Novavax, Inc. read more

Novartis to work with FDA on path forward for RLX030 for acute heart failure following Advisory Committee outcome »

[at noodls] – Novartis believes RLX030 has the potential to be an important treatment for AHF, a disease with lower survival rates than many advanced cancers or a heart attack Second phase III study RELAX-AHF-2 started … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click […]

March 28, 2014 Bystocknews , Comments Off on Novartis to work with FDA on path forward for RLX030 for acute heart failure following Advisory Committee outcome » read more